Bill Gates on Tuesday called for South Korea to further step up to prevent infectious diseases like COVID-19 as he stressed the need for the world to be better prepared for the next pandemic.
Adar Poonawalla, CEO and brain behind the new age SII, says in an interaction with Business Standard that by the end of 2021, the company was making 250 million doses a month
Analysis shows that by September 29, the country will cover 28.6 per cent of the eligible population of 796 million who will be due for the booster dose
Goa Health Department has set a target to administer precautionary doses of Covid-19 vaccine to 10.5 lakh people in next two months, for which it has decided to rope in various departments.
Study shows booster jab is effective against several Sars-CoV-2 strains such as Alpha, Beta, Delta, Delta Plus and Omicron, and also increases memory B-cell response
Govt learns from mistakes but the fight isn't over
The inclusion of this vaccine in the NIM is a significant step in reducing cervical cancer burden among women
India started vaccinating adolescents (aged 15-18) from January, and further expanded the drive to include children as young as 12 years from March
While more than 7 million deaths were likely averted in countries covered by Covax, the WHO-backed distribution program, the research nonetheless highlights the devastation caused by uneven access
Denial of doses to persons without IDs, absence of segregated data and low awareness pose question mark on campaign
Fewer than 20% have taken precautionary vaccine dose, with Delhi, Mumbai and Bengaluru accounting for a quarter of the jabs taken by the 18-59 age group
About 375 million people over the age of 15 in China have yet to receive three doses of a vaccine, while the daily vaccination rate has fallen below 800,000 per day
Even as cases in the country rise, the pace of vaccination is falling
Germany's independent vaccine advisory panel is recommending that shots against monkeypox be prioritised for people recently exposed to the virus that causes the disease. The panel, known by its German acronym STIKO, circulated a draft recommendation Thursday in which it said that due to limited supply, the smallpox vaccine Imvanex should be made available first to people who were exposed to the virus in the previous 14 days. Two shots should be given at least 28 days apart to people not previously vaccinated against smallpox, while a single dose is enough for those who had received a smallpox shot before, the advisory panel said. Monkeypox is a rare disease, related to the same virus family as smallpox. The panel said that people at heightened risk of contracting monkeypox should be given second priority for the vaccine. This includes men who have sex with changing male partners; all of the more than 130 monkeypox cases in Germany so far have involved individuals in that group. St
'Vaccine equity not possible if we include imported mRNA vaccines in our programme', said Arora
Many outside the richer economies are still awaiting the gift of the jab
'Let's not make a mountain out of a molehill,' says WHO official; France, Denmark latest to consider target vaccinations
The WHO has said that there is benefit of administering an additional booster dose of the mRNA Covid-19 vaccine for highest risk groups
On May 4, Biological E submitted an application seeking emergency use authorisation for its Covid vaccine Corbevax as a booster dose in adults fully vaccinated with Covishield or Covaxin
The National Technical Advisory Group on Immunisation (NTAGI) will hold its crucial meeting on vaccine for children next week